Le Lézard
Classified in: Health, Business
Subjects: HSP, CXP

GI Alliance Expands Presence in San Antonio


DALLAS, Oct. 21, 2019 /PRNewswire/ -- GI Alliance, the nation's leading physician-led GI services organization, announced today that it has partnered with 17 physicians in San Antonio from the practices of San Antonio Gastroenterology Associates (SAGA) and San Antonio Digestive Disease Consultants (SADDC). The founders of SAGA built the first freestanding endoscopy center in downtown San Antonio in 1980 and have established themselves as a leading provider of GI medicine in the area.

San Antonio has grown to become the 7th largest city in the United States, with over 1.5 million residents.  This image features one of the city's most famous attractions, the San Antonio River Walk.

"We are pleased to welcome the physicians of SAGA and SADDC and their staff to the GI Alliance family," said Dr. Jim Weber, CEO of GI Alliance. "Even with our growth on the national stage, we maintain our commitment to expand in Texas, furthering the delivery of high-quality patient care by supporting talented gastroenterologists with our experience and infrastructure."

"We are excited to have found a true partner that brings unparalleled resources to our growing practice," said Ernesto Guerra, M.D., SAGA President.  "This allows us to stay focused on what matters most, which is improving the outcomes for our patients.  GI Alliance understands that although the business of medicine is centralized, the practice of medicine is local."

About GI Alliance
GI Alliance is a physician-led, GI services organization supporting the needs of more than 290 independent gastroenterologists operating in Texas, Louisiana, Illinois, Arizona and Indiana. GI practices that are part of the GI Alliance are focused on providing the highest-quality care to their patients. In addition to providing operational support for GI practices, GI Alliance is working to unite gastroenterologists nationwide to align interests and improve quality of care for patients.

Contact: Brittany Dodd / GI Alliance
Marketing@GIAlliance.com
(817) 402-7562 
www.gialliance.com

GI Alliance (PRNewsfoto/GI Alliance)

SOURCE GI Alliance


These press releases may also interest you

at 04:23
Enzymatica and its partner STADA have extended its agreement for the cold spray ViruProtect® (ColdZyme) to cover another 19 countries in Europe. With the extended agreement STADA has provided order estimates of about SEK 20 million for 2020. The...

at 04:00
As governments in many countries are easing lockdown restrictions, fitness facilities are getting ready to re-open and welcome back customers. After the pandemic, health has certainly risen to the top of the list of consumers' personal priorities,...

at 03:30
The "Global Molecular Point of Care (mPOC) Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The molecular point of care (mPOC) devices market is poised to grow by $ 816.62 million during 2020-2024 progressing at...

at 03:25
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the ongoing EMA review of imlifidase for a potential marketing authorization in Europe is on track. A CHMP opinion is expected at...

at 02:05
POXEL S.A. (Euronext ? POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) ("Poxel", or the "Company"),...

at 02:05
POXEL SA (Euronext: POXEL FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced new preclinical...



News published on 21 october 2019 at 09:00 and distributed by: